Ergothioneine is a fungal metabolite that may have antioxidant functions in mammalian cells. Although it accumulates to low millimolar concentrations in liver and other tissues, it is not thought to be taken up by mature erythrocytes. During a study of the function of ergothioneine as an antioxidant in human erythrocytes, we found that these cells do take up ergothioneine from the surrounding medium. Ergothioneine concentrations in freshly prepared erythrocytes were 2-9-fold higher than in plasma from the same donor. Slow but progressive accumulation of ergothioneine to about 125 % of basal levels was observed in erythrocytes over a 4 h incubation. After a 2 h incubation, intracellular ergothioneine concentrations rose on addition of increasing amounts of ergothioneine to the incubation medium, although saturation was not evident in cells from all donors. Both initial levels and rates of ergothioneine uptake varied in erythrocytes from different donors. Intracellular ergothioneine was stable to depletion of GSH by N-ethylmaleimide and to a more severe oxidant stress induced by hydrogen peroxide in the presence of catalase. These results show that human erythrocytes do take up ergothioneine ; however, the GSH results do not support an antioxidant role for ergothioneine in erythrocytes.
INTRODUCTION
Ergothioneine (ERT ; 2-mercaptohistidine trimethylbetaine) is a fungal metabolite that is found in relatively high concentrations in numerous animal tissues [1] . Since animals cannot synthesize ERT [1] , there must exist mechanisms for its uptake and retention within cells. The presence of ERT in human erythrocytes, but not in plasma, is such an example. However, there is controversy regarding whether or not ERT is taken up by erythrocytes. Early studies failed to demonstrate uptake of ERT into human erythrocytes following incubation for as long as 4 h [1, 2] . A subsequent in vivo study in rats did show that orally administered [$H]ERT was subsequently found in erythrocytes and not plasma [3] . Nevertheless, the failure of early studies to show erythrocyte uptake of ERT, and the finding that ERT levels in erythrocytes decline with age of the cells [4] , prompted Hartman [5] to concur with Melville's analysis [1] that there is no transport of ERT into mature erythrocytes.
The function of ERT also remains an enigma [6, 7] . ERT exists as a thione-thiol tautomer, with the thione form predominating in aqueous solutions. Since it scavenges strong oxidants such as hydroxy radicals [8] , hypochlorite [8] and peroxynitrite [8] in vitro, and since it chelates redox-active bivalent cations such as Cu# + [5, 8] , ERT has been considered to function primarily as an antioxidant within cells. There is increasing evidence that cellular antioxidant status, which is reflected in GSH content [9] , correlates with resistance to lipid peroxidation in atherosclerosis, smoking and diabetes [10] . In contrast with aliphatic thiols such as GSH, however, ERT does not form disulphides and mixed disulphides under physiological conditions [1] , but requires a more severe oxidative stress to oxidize and remove the sulphur atom. During an investigation of a potential antioxidant role for ERT in human erythrocytes, we found instead that these cells do take up and retain ERT in a time-and concentration-dependent manner. 
METHODS

Materials
Preparation of human erythrocytes
Blood was obtained by venipuncture from normal volunteers and anticoagulated with heparin. Erythrocytes were washed three times in 5 vol. of PBS, with careful removal of the buffy coat of leucocytes after each centrifugation (600 g for 5 min). PBS consisted of deionized water that contained 12.5 mM Na # HPO % and 140 mM NaCl, pH 7.4. The cells were suspended to the final haematocrit as noted for incubations. This study was approved by the Vanderbilt University Institutional Review Board, and subjects gave their written consent.
Assay of ERT and GSH
ERT in plasma and erythrocytes was measured by the method of Carlsson et al. [11] , with the following modifications to simplify and shorten sample processing before assay. Packed, washed erythrocytes (0.2 ml) were diluted with 0.6 ml of PBS that had been adjusted to pH 8.0. The suspension was frozen in solid CO # \acetone, thawed on ice and centrifuged at 5000 g for 40 min at 3 mC in Centricon-10 tubes (Amicon, Inc., Beverly, MA, U.S.A.). ERT was assayed in plasma following dilution and ultrafiltration, but a freeze-thaw step was unnecessary. The resulting 300-400 µl of clear ultrafiltrate from cells or plasma was frozen and lyophilized to dryness, usually overnight. The residue was suspended in 0.5 ml of 50 mM sodium phosphate buffer containing 100 µM CuSO % , pH 9.5. Samples were incubated for 1 h at 37 mC. During this incubation the pH did not fall below 9.3. Duplicate 0.2 ml aliquots of the samples were then transferred to acrylic spectrophotometric cuvettes that contained 0.5 ml of 1.5 mM 2,2h-dipyridyl disulphide and 120 µl of 1 M HCl. The 2,2h-dipyridyl disulphide was dissolved in a small amount of DMSO and diluted to a final DMSO concentration of 0.5 % (v\v) for use in the assay. Sample absorbance was read at 343 nm, corrected for a reagent blank, and compared with readings obtained for freshly prepared ERT standards in each assay. The assay was linear up to 80 µM ERT, with a lower limit of detection of about 2.5 µM (results not shown). This allowed measurement of plasma ERT concentrations as low as 30 µM, and erythrocyte concentrations as low as 45 µM. The coefficient of variation in an assay was 3.9 %.
Erythrocyte concentrations of GSH were measured using the fluorimetric assay of Hissin and Hilf [12] . Samples were prepared for this assay by lysis of 50 µl of packed erythrocytes in 5 % (v\v) m-phosphoric acid.
Results for both ERT and GSH are expressed per ml of erythrocyte cytosol, which was taken to be 70 % of the packed-cell volume [13] .
RESULTS
The modified dipyridyl disulphide assay for ERT proved suitable for measuring ERT concentrations in both plasma and erythrocytes. ERT concentrations within erythrocytes were 2-9-fold greater in erythrocytes than in the plasma from which the erythrocytes were taken (Figure 1 ). The range of ERT concentrations in erythrocytes from different donors was broad. There was less variability between samples taken from the same individual on different days. The consistent difference in plasma compared with erythrocyte ERT concentrations prompted studies to determine whether erythrocytes can take up ERT in vitro.
Incubation of erythrocytes with 1 mM ERT resulted in a gradual uptake of ERT into the cells over a 4 h incubation period (Figure 2, upper panel) . Because of variability in the initial level of ERT in the cells from different donors, individual time courses are shown. ERT concentrations increased on average about 25 % in the cells, with most of the increase occurring during the first 2 h of incubation ( Figure 2 , lower panel). Addition of 1 mM GSH in several experiments was without effect on the cellular content of ERT. This indicates that the apparent uptake of ERT is due to its entry into the cells, and not to the formation of mixed disulphides with free thiols on the cell surface, since GSH would have reduced such disulphides and released ERT. Incubation of erythrocytes with increasing concentrations of ERT for 2 h also increased intracellular ERT concentrations (Figure 3) . Again, the basal levels and extent of uptake were variable in the three different donors studied. There was a tendency to reach limiting intracellular ERT concentrations, but this effect was not consistent. Together with the time-course results, these data suggest that human erythrocytes do take up ERT, although the extent of uptake is variable from donor to donor. Attempts to inhibit ERT uptake with glycine and betaine at concentrations up to 10 mM were unsuccessful.
To determine whether ERT concentrations in erythrocytes are affected by an oxidant stress, cells were first depleted of GSH with N-ethylmaleimide (NEM). As shown in Figure 4 , intracellular GSH was almost completely alkylated by 0.7 mM NEM. However, there was no effect on intracellular ERT concentrations. Similarly, as shown in Figure 5 , exposure of the cells to concen- 
DISCUSSION
Despite previous results to the contrary [1,2,14], we found that ERT is taken up unchanged by human erythrocytes. The most likely reason for our ability to demonstrate such uptake was the use of a more specific assay for ERT than was used in the early studies. Although assay of ERT by HPLC with electrochemical detection has been described, and is more sensitive and specific than spectrophotometric assays, not all HPLC methods have proved to be reproducible, as noted by Muda et al. [15] . Since it does not require a dedicated HPLC system, and since it is amenable to the assay of multiple samples at once, we adopted the simple spectrophotometric method of Carlsson et al. [11] . To ensure specificity, this assay requires removal of interfering substances such as ascorbate and GSH by the use of copper oxidation at an alkaline pH, conditions that do not destroy ERT. We modified the assay in several respects. We lysed cells without denaturation and collected the cytosol by ultrafiltration. We also scaled down the assay for use with small sample volumes, and used lyophilization instead of a heat-drying step to concentrate samples. These changes allowed multiple samples to be processed in a single day, or in two half-days with overnight lyophilization.
As observed previously in different assays [15] [16] [17] , we found significant variation between blood donors in basal plasma and erythrocyte ERT levels. This probably relates to different dietary intakes of ERT [1] . However, our finding that ERT concentrations in erythrocytes were much higher than those in plasma (Figure 1) shows that erythrocytes can maintain intracellular ERT against a concentration gradient. It was shown previously that radioactive ERT administered to rats left the plasma over several hours, and was found in numerous tissues, including liver and kidney, and in erythrocytes [3] . The ERT concentration in liver was 10-fold higher than that in blood. Thus many cells appear to concentrate ERT, although the mechanism of its uptake is unknown. The most likely mechanism is uptake on a transport protein, such as the one that transports glycine and betaine into renal tubular cells [18, 19] , or the one that transports taurine into skate erythrocytes [20] . However, in preliminary studies we did not find that ERT uptake was affected by either glycine or betaine.
The clinical significance of the concentrative uptake of ERT into cells and tissues remains to be established. In addition to possible antioxidant effects, it has been hypothesized that ERT is involved in cation transport, thyroid hormone action, gene expression and repair, and immunoregulation [6, 7] .
ERT has long been considered as a stable internal standard for measuring erythrocyte GSH by proton NMR spectroscopy [21] . Treatment of erythrocytes with dimethylarsenic acid (cacodylate) [22] or with the thiol oxidant 5,5h-dithiobis-(2-nitrobenzoic acid) [23] was found to decrease the NMR signals of both GSH and ERT in spin-echo NMR studies. However, the chemical changes responsible for these decreases were not defined, and they were subsequently attributed to artifacts induced by the experimental conditions [21] . Since both the thione and thiol forms of ERT react in the dipyridyl disulphide assay, our results would have shown only more significant oxidation of the sulphur, and this was not observed, either following GSH depletion with NEM or following its oxidation by H
The failure of erythrocyte ERT concentrations to change following substantial alkylation or oxidation of GSH supports the use of ERT as an internal standard for measurement of GSH by proton NMR spectroscopy.
Whereas NEM readily alkylates GSH, ERT does not appear to react directly with NEM in vitro [5] . Our results confirm this in intact cells, since we saw no decrease in ERT under conditions whereby GSH was completely depleted (Figure 4 [24] that may be a tyrosine peroxy radical [8] . Scavenging of such a radical may account for the ability of ERT in in vitro studies to inhibit arachidonic acid peroxidation induced by haem compounds and H # O # [8] . The resulting thiyl radical of ERT can be reduced by ascorbate [25] . Under such conditions, however, ascorbate would have been oxidized first. The failure of H # O # treatment of erythrocytes to lower ERT concentrations when GSH is partially depleted suggests that oxidative loss of ERT does not occur. To the extent that changes in GSH content reflect cellular oxidant stress, our results fail to support the hypothesis that physiologically attainable ERT concentrations within erythrocytes might help in the defence against H # O # -induced cytotoxicity [5] .
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